Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Boehringer Ingelheim
Chinese Patent Office
Johnson and Johnson

Generated: January 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019737

« Back to Dashboard

NDA 019737 describes METROGEL, which is a drug marketed by Galderma Labs Lp and Medicis and is included in three NDAs. It is available from five suppliers. There are two patents protecting this drug and two Paragraph IV challenges. Additional details are available on the METROGEL profile page.

The generic ingredient in METROGEL is metronidazole. There are eighteen drug master file entries for this compound. Eighty-five suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
Summary for 019737
Applicant:Galderma Labs Lp
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 019737
Suppliers and Packaging for NDA: 019737
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METROGEL metronidazole GEL;TOPICAL 019737 NDA AUTHORIZED GENERIC Prasco Laboratories 66993-962 66993-962-45 1 TUBE in 1 CARTON (66993-962-45) > 45 g in 1 TUBE
METROGEL metronidazole GEL;TOPICAL 019737 NDA AUTHORIZED GENERIC Owen Laboratories 69007-835 69007-835-45 1 TUBE in 1 CARTON (69007-835-45) > 45 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;TOPICALStrength0.75%
Approval Date:Nov 22, 1988TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.